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Abstract
Background: The development of the in vitro cell culture model has greatly facilitated the ability to study gene
expression and regulation within human tissues. Within the human uterus, the upper (fundal) segment and the
lower segment may provide distinct functions throughout pregnancy and during labour. We have established
primary cultured human myometrial cells, isolated from both upper and lower segment regions of the pregnant
human uterus, and validated them for the purpose of studying human pregnancy and labour. The specific
objectives of this study were to monitor the viability and characterize the expression profile using selected cellular,
contractile and pregnancy associated markers in the primary cultured human myometrial cells. Labour has been
described as an inflammatory process; therefore, the ability of these cells to respond to an inflammatory stimulus
was also investigated.
Methods: Myometrial cells isolated from paired upper segment (US) and lower segment (LS) biopsies, obtained
from women undergoing Caesarean section deliveries at term prior to the onset of labour, were used to identify
expression of; a smooth muscle actin, calponin, caldesmon, connexin 43, cyclo-oxygenase-2 (COX-2), oxytocin
receptor, tropomyosin and vimentin, by RT-PCR and/or immunocytochemistry. Interleukin (IL)-1b was used to treat
cells, subsequently expression of COX-2 mRNA and release of interleukin-8 (CXCL8), were measured. ANOVA
followed by Bonferroni’s multiple comparisons test was performed.
Results: We demonstrate that US and LS human myometrial cells stably express all markers examined to at least
passage ten (p10). Connexin 43, COX-2 and vimentin mRNA expression were significantly higher in LS cells
compared to US cells. Both cell populations respond to IL-1b, demonstrated by a robust release of CXCL8 and
increased expression of COX-2 mRNA from passage one (p1) through to p10.
Conclusions: Isolated primary myometrial cells maintain expression of smooth muscle and pregnancy-associated
markers and retain their ability to respond to an inflammatory stimulus. These distinct myometrial cell models will
provide a useful tool to investigate mechanisms underlying the process of human labour and the concept of
functional regionalization of the pregnant uterus.
Background
Efforts to understand mechanisms regulating the balance
between uterine quiescence and contractions are a main
focus of research in obstetrics, especially preterm labour.
Of particular interest are the myometrial smooth muscle
cells as these constitute the contractile machinery of the
uterus and may offer a therapeutic target for the preven-
tion of premature myometrial contractions. Cell culture
provides a valuable in vitro tool to study many human tis-
sues and organs with the potential to gain insight into var-
ious physiological and pathological processes. However,
there are concerns about the lifespan of cultured primary
cells and their ability to continue to be representative of
the tissue of origin. Therefore, we have established
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primary cultured human myometrial cells isolated from
myometrial tissue biopsies obtained during elective Cae-
sarean section deliveries at term, prior to the onset of
labour, and validated their usefulness for studying preg-
nancy and labour.
It has been hypothesized that the upper and lower
regions of the human uterus are functionally distinct [1].
During labour, the upper segment has a more contractile
phenotype, contracting to push down and initiate deliv-
ery of the baby, whilst the lower segment, maintains a
more relaxed phenotype, to facilitate delivery of the baby
through the lower segment of the uterus and cervix. A
number of genes, thought to be involved in the onset of
labour, have been shown to be differentially expressed in
upper and lower segment myometrial tissues [2-7]. These
observations support the notion that upper and lower
segments of the pregnant human uterus may be function-
ally distinct.
The objective of the current study was to establish pri-
mary cultures of human myometrial cells isolated from
paired upper and lower segment myometrial biopsies for
ten passages and evaluate and compare the expression of
smooth muscle markers, fibroblast markers, contractile
proteins or labour associated proteins over time. For the
purpose of this study, smooth muscle markers were
defined as; a smooth muscle actin, calponin, caldesmon,
and tropomyosin, since a smooth muscle actin is part of
the contractile machinery of smooth muscle cells and cal-
ponin, caldesmon, and tropomyosin are proteins that
modulate muscle cell contractility through their ability to
bind to a smooth muscle actin [8-10]. Fibroblast markers
used were vimentin, a filament protein that is typically
used to identify fibroblasts [11,12] and a fibroblast surface
protein called IB10 (http://Abcam.com). The gap junction
protein, connexin 43 and the oxytocin receptor are labour
associated genes known to be up-regulated at the time of
labour onset in human myometrium [3,5,13,14].
In addition, labour is commonly considered an inflam-
matory process and up-regulation of inflammatory genes
including interleukin-1b (IL-1b), cyclo-oxygenase-2
(COX-2) and interleukin-8 (CXCL8) is observed
[15-17,5]. We therefore tested the ability of the upper
segment myometrial cells to respond to an inflammatory
stimulus compared to lower segment cells. For this study,
interleukin-1b (IL-1b) was used as the inflammatory sti-
mulus, and cyclo-oxygenase-2 (COX-2) mRNA expres-




Institutional ethical committee approval was obtained
(Conjoint Health Research Ethics Board, Office of Medical
Bioethics at the University of Calgary) for the collection of
myometrial biopsies to study the mechanisms of human
labour. Women undergoing delivery by elective caesarean
section at term were recruited, fully informed and con-
sented to the study. In the current study, none of the
women had any known underlying diseases, all were
Caucasian with ages ranging from 25-41. Indications for
caesarean delivery included breech presentation or pre-
vious caesarean delivery. Gestational age ranged from
38 weeks + 4 days to 39 weeks + 0 days and no clinical
signs of labour were observed. Paired biopsies were col-
lected from the lower and upper regions of the uterus
following delivery of the infant. The lower segment biopsy
was taken from the exposed myometrium on the upper
aspect of the lower segment incision. The upper segment
biopsies were all taken from the side opposite the placenta
on the anterior or posterior aspect of the upper segment.
Palpation and visualization of the uterus determined
where the upper segment begins and samples were taken
from approximately half way between the upper edge of
the lower segment incision and the tip of the fundus. For
the upper segment biopsy, the decidual layer was first dis-
sected away and a small piece of myometrium grasped
with fine forceps and dissected with Iris scissors. All sam-
ples were placed immediately into sterile cold Hank’s
Balanced Salt Solution (HBSS) (Life Technologies, Burling-
ton, ON, Canada), containing antibiotic-antimycotics
(1x Penicillin-Streptomyocin-Amphotericin B) (Gibco, Life
Tecnologies, Inc), and transported to the laboratory for
myometrial cell isolation within 30 minutes of delivery.
Isolation and culture of primary human myometrial cells
Myometrial cells were isolated, separately but in parallel,
from the paired, upper segment (US) and lower segment
(LS) myometrial biopsies. Myometrial cells were isolated
from methods adapted from Phaneuf et al., [18] and Tribe
et al., [19]. Each biopsy was dissected into 1 mm3 pieces,
washed in HBSS to remove excess blood, placed in
Smooth Muscle cell medium containing collagenase XI
(1 mg/ml), collagenase IA (1 mg/ml) and fatty acid free
bovine serum albumin (0.5%) (Sigma-Aldrich, Oakville,
ON, Canada), and digested for 60 minutes at 37oC. Myo-
metrial cells were then dispersed by passing the digestion
solution repeatedly through a fine sterile pipette, further
digestion was stopped by the addition of 5% fetal bovine
serum (FBS) (Life Technologies) contained in Smooth
Muscle Medium (PromoCell, Heidelberg, Germany). Cells
were passed through a 70 μm sieve, centrifuged for 5 min-
utes at 400 g, and re-suspended in Smooth Muscle
Medium containing 5% FBS and 1x antibiotic-antimycotic.
Isolated cells were assessed for viability by the Trypan
Blue exclusion method (Life Technologies Inc.) and
counted using the Countess Automated Cell Counter (Life
Technologies Inc.). Cells were plated into 25 cm2 culture
flasks (Corning Inc., Lowell, MA, USA), incubated at 37oC
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in a humidified atmosphere of 95% air/5% CO2 and the
culture medium replaced every 2 days. The initial stage of
cell growth was termed passage 0 (p0). At approximately
10-14 days following initial isolation when myometrial cell
growth reached 80-90% confluence (% coverage of cells in
the culture flask) the cells were sub-cultured (passaged)
and plated at a density of 4.0 x 104 cells/ml into a larger
150cm2 culture flask and termed, passage 1 (p1).
For the current series of experiments LS and US myo-
metrial cells were sub-cultured from passage 1 through to
passage 10 at a density of 4.0 x 104 cells/ml into a 150 cm2
culture flask and 12-well plates (Corning Inc.) to assess
changes in; (i) cell viability and population doubling,
(ii) expression of contractile markers (mRNA and protein)
and, (iii) the response to treatment with the inflammatory
mediator interleukin-1b (IL-1b). Prior to experiments, all
cells were serum deprived overnight (Smooth Muscle
Medium 0.5% FBS), then incubated for 6 hours with either
1 ng/ml IL-1b (Research & Development Systems,
Minneapolis, MN, USA) or non-treated (NS). Culture
supernatants were collected and stored at -20oC while cell
culture plates were stored at -80oC prior to RNA isolation.
RNA isolation, conventional RT-PCR and real-time RT-PCR
Total RNA was isolated from human myometrial cells
using the Qiagen RNeasy Mini Kit (Qiagen Inc., Toronto,
ON, Canada) and 500 ng used for reverse transcription
and synthesis of complementary DNA (cDNA) with
qScript cDNA SuperMix (Quanta BioSciences Inc.,
Gaithersburg, MD, USA). Negative reverse transcription
reactions were performed as a control, in which the
reverse transcriptase enzyme was absent. Conventional
RT-PCR was performed on an Eppendorf EPS Mastercy-
cler (Eppendorf Canada, Mississauga, ON, Canada) with
an initial denaturing step of 2 minutes at 94oC, followed
by 32-36 cycles of denaturing at 94oC, annealing at 58oC
-60oC, and elongation at 72oC, with a final elongation
step at 72oC for 5 minutes. RT-PCR products were first
analyzed by agarose gel electrophoresis to confirm
the RT-PCR amplification product was the correct size.
Subsequently, RT-PCR products were purified using a
Qiagen MinElute PCR Purification Kit (Qiagen Inc.),
and verified by sequencing (DNA Sequencing Services,
University of Calgary). Real-time RT-PCR was performed
on the Applied Biosystems 7900HT machine in 96-well
Fast Optical MicroAmp Plates (Applied Biosystems, Life
Technologies) with SYBR Green qPCR SuperMix
(Quanta BioSciences Inc.). All protocols were performed
according to manufacturer’s instructions. See Table 1 for
PCR primer sequences. Melt curve analysis was per-
formed to verify that non-specific amplification products
Table 1 Primer sequences



























































Sequence of primers used for conventional and real-time RT-PCR analysis.
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were not present. Gene expression was normalized to the
reference gene b2-microglobulin (B2M) and results
calculated using the ΔΔCT method [20].
ELISA
The chemokine, CXCL8 was quantified by a sandwich
enzyme-linked immunosorbent assay (ELISA) (Human
DuoSet®, Research & Development Systems, Minneapolis,
MN, USA) according to manufacturer’s instructions.
Optical density was measured at 450 nm using a DTX880
Multimode Detector (Beckman Coulter Canada Inc., Mis-
sissauga, ON, Canada).
Immunocytochemistry
Cells were also seeded onto 8-chamber glass culture slides
(ThermoFisher Scientific, Ottawa, ON, Canada) at passage
1, passage 5 and passage 10 and grown to 80-90% conflu-
ence. Cells were rinsed in phosphate-buffered saline (PBS),
fixed in 4% paraformaldehyde for 20 minutes at 37oC and
permeabilized in 0.1% Triton-X in PBS for 15 minutes at
room temperature. Myometrial cells were treated using a
Dako kit (Dako Canada Inc., Burlington, ON, Canada)
according to the manufacturer’s instructions. Briefly, cells
were incubated for 10 minutes in 1.5% blocking serum in
PBS at room temperature prior to incubation with primary
antibody (Table 2). Cells were washed in PBS and in-
cubated with biotinylated goat anti-rabbit and anti-mouse
secondary antibody followed by peroxidase substrate.
Finally, cells were counterstained in Harris’ haematoxylin
and mounted with Dako Faramount Aqueous Mounting
Medium. Images were obtained using a Zeiss Axio Scope
connected to an Axiocam ICc 3 camera and AxioVision
4.8.2 software (Carl Zeiss Canada Ltd., BC, Canada).
Statistical analysis
All experiments were performed using paired upper
and lower segment cells isolated from n=4 patients. All
statistical analysis was performed with GraphPad PRISM
Software (GraphPad Software Inc., San Diego, CA, USA).
Graphical data are presented as the mean ± SEM. For
comparison between two groups, Student’s t test were
used and for multiple comparisons a one-way analysis of
variance (ANOVA) followed by post-hoc test of Bonfer-
roni multiple comparisons. P < 0.05 was considered sta-
tistically significant.
Results
Through the ten passages cell viability ranged from 78.0
- 93.75% and 79.5 - 92.5% in the US and LS cells
respectively. There were no significant differences in cell
viability through passage (p1 to p10) or when comparing
cells isolated from the US versus the LS uterus as shown
in Figure 1.
Upper and lower segment human myometrial cells
express smooth muscle and fibroblast markers
Total RNA was isolated from treated and non-treated
upper and lower segment human myometrial cells
(p1 to p10). Conventional RT-PCR was used to identify
the presence of calponin (a smooth muscle marker; gene
name CNN1), vimentin (a fibroblast marker; gene name
VIM), and connexin-43 (a gap junction protein; gene
name GJA1). GAPDH and B2M were used as reference
housekeeping genes for conventional and real-time RT-
PCR respectively. All four genes were positively identified
in both upper and lower segment cells. CNN1, VIM, and
GJA1 mRNA expression were not affected by IL-1b treat-
ment (Figure 2A). Qualitative data for p1 to p4 is shown
in a representative agarose gel figure. The same trend was
also observed for p5 to p10 (data not shown). Real-time
RT-PCR was then used to quantify mRNA expression
comparing upper and lower segment myometrial cells and
to determine any changes through passage 1 to 10. Signifi-
cantly higher expression of VIM (P = 0.032) and GJA1
(P < 0.0001) but not CNN1 (P = 0.06) was observed in
lower segment cells (Figure 2B). Expression of VIM,
CNN1 (Figure 3A and B) or GJA1 (data not shown)
mRNA were not significantly different through p1 to p10.
Upper and lower segment human myometrial cells
differentially express COX-2 and respond to an
inflammatory stimulus for at least ten passages
To investigate the upper and lower segment human myo-
metrial cells and the response of the cells to IL-1b, expres-
sion of cyclo-oxygenase (an inflammatory gene known to
be increased during pregnancy and labour; gene name
COX-2) mRNA was quantified by real-time RT-PCR and
CXCL8 output was measured by ELISA. These outputs
were chosen because both COX-2 and CXCL8 are demon-
strated to increase in human myometrium with labour
[2,16]. Expression of COX-2 was first examined comparing
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upper segment versus lower segment cells, In non-treated
cells expression of COX-2 was significantly higher in lower
segment cells compared to upper segment cells (P <
0.0001) (Figure 4A). Treatment with IL-1b significantly
increased COX-2 expression in upper segment cells
(Figure 4B) and lower segment cells (Figure 4C). Figure 4D
demonstrates the relative expression of COX-2 as a
direct comparison in upper, lower, non treated and IL-1b
Figure 1 Cell viability from p1 to p10 Viability (% live cells) of cultured upper segment (black bars) and lower segment (grey bars) myometrial
cells at passage (p1 through p10). Values represent mean +/- SEM.
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Figure 2 Expression of calponin, vimentin and connexin-43 mRNA in upper and lower segment myometrial cells (A) Representative
agarose gel demonstrating expression of calponin (CNN1), vimentin (VIM), connexin 43 (GJA1) and GAPDH mRNA expression in upper and lower
segment myometrial cells through passage 1 (p1) to passage 4 (p4) in non-treated (NS) and IL-1b (IL)-stimulated cells by conventional RT-PCR
analysis. (B) Real-time RT-PCR analysis identified significantly higher expression of VIM and GJA1 in LS myometrial cells (grey bars) compared to
US cells (black bars). Data are presented as the mean ± SEM of all LS and US cells from p1 through p10 and analyzed by student t test.
(** P=0.003, *** P<0.0001).
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treated cells. IL-1b treatment results in increased expres-
sion of COX-2 in both upper and lower segment cells
but the increase is much higher in the lower segment cells
(Figure 4D).
Comparing passage number, treatment with IL-1b
resulted in a robust increase in COX-2 mRNA expression
compared to the non-treated in both upper (ANOVA
P=0.0007) and lower (ANOVA P<0.0001) segment cells
Figure 3 Effect of passage (p1 through p10) on mRNA expression Relative expression of (A) calponin (CNN1), and (B) vimentin (VIM)
normalized to the reference gene b2-microglobulin (B2M). Data represent the mean ± SEM from US (black) and LS (grey) non-treated cells.
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(Figure 5). Treatment with IL-1b also resulted in a robust
release CXCL8 (20 000-50 000 pg/ml) in upper (ANOVA
P<0.0001) and lower (ANOVA P=0.0013) segment cells
from p1 through p10 (Figure 6). There were no changes in
the response to Il-1b from p1 through p10. Therefore,
both upper and lower segment human myometrial cells
retain their ability to respond to an inflammatory stimulus
as demonstrated by increased expression of the inducible
COX-2 gene and increased release of the pro-inflamma-
tory chemokine CXCL8.
Upper and lower segment human myometrial cells stain
positively for smooth muscle markers, fibroblast protein
markers and contractile proteins
Human myometrial cells were seeded on 8-chamber cul-
ture slides at passage 2, passage 5 and passage 10 and trea-
ted with antibodies to identify protein expression of
smooth muscle markers, fibroblasts markers, and the oxy-
tocin receptor (a contractile protein expressed in the preg-
nant uterus). Upper and lower segment human myometrial
cells stained positively for a smooth muscle actin, caldes-
mon, calponin, tropomyosin, the oxytocin receptor, vimen-
tin and 1B10 at p2, p5 and p10. On the whole similar
staining patterns were observed at p2, p5 and p10, it was
noted that staining for both tropomyosin and the oxytocin
receptor appeared to be lighter at p10 compared to p2 how-
ever quantitative and statistical analysis was not performed
due to the qualitative nature of the technique. (Figure 7)
shows representative slides from (A) p2 and (B) p10.
Discussion
In this study, we have shown that primary cells isolated
and cultured from paired myometrial biopsies are viable
and responsive for at least ten passages. Upper and lower
Figure 4 Differential expression of COX-2 in LS versus US myometrial cells Expression of COX-2 expression is significantly higher in the
lower segment versus the upper segment in non-treated cells (A). Treatment with IL-1b significantly increases COX-2 expression in both upper
segment (B) and lower segment (C) cells. Panel (D) shows for comparison the relative levels of COX-2 expression in all four groups. Relative
expression of COX-2 normalized to B2M. Data represent the mean ± SEM of US (black) and LS (grey) cells, analyzed by student t test through all
passages (***P<0.0001).
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segment human myometrial cells continue to grow,
divide and respond to an external stimulus. From
p1 through to p10, upper and lower segment cells res-
pond to IL-1b treatment measured by increased gene
expression (COX-2) and pro-inflammatory chemokine
release (CXCL8).
Human myometrial cells are elongated, spindle-shaped
cells and this morphology is maintained up to p10 with
Figure 5 IL-1b stimulates COX-2 mRNA expression in myometrial cells from p1 through p10 Relative expression of COX-2 normalized to
B2M. Data represent the mean ± SEM of US (black) and LS (grey) myometrial cells. For simplicity only data from p2, p4, p6, p8 and p10 are
depicted in the graph. NS = non-treated cells; IL = IL-1b-stimulated cells. ANOVA (P=0.0007 in upper and P<0.0001 in lower segment).
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no discernible alterations in cell shape, size, or structure,
as assessed by light microscopy. Cultured human myo-
metrial cells expressed both smooth muscle markers (a
smooth muscle actin, calponin, caldesmon, tropomyosin)
and fibroblast markers (vimentin, 1B10), suggesting that
they may represent an intermediate myofibroblast phe-
notype or possibly a mixed population of myometrial
smooth muscle cells and myofibroblasts. However,
Figure 6 IL-1b-induced CXCL8 output from p1 through p10 IL-1b stimulates release of CXCL8 from both upper (black) and lower (grey)
segment myometrial cells Paired upper and lower segment human myometrial cells were non-treated (NS) or treated with IL-1b (IL). The culture
supernatant was collected and CXCL8 output was quantified by ELISA. Data represent the mean ± SEM. Only data from p2, p4, p6, p8 and p10
are depicted in the graph. ANOVA (P<0.0001 in upper and P=0.0013 in lower segment).
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Figure 7 Expression of smooth muscle markers, fibroblast markers and contractile proteins in upper and lower segment myometrial
cells Immunocytochemistry of (a) a smooth muscle actin, (b) caldesmon, (c) calponin, (d) tropomyosin, (f) Vimentin, (g) IB10, and the
(h) oxytocin receptor in; (A) upper segment myometrial cells at p2, (B) lower segment myometrial cells at p2, (C) upper segment myometrial
cells at p10 and (D) lower segment myometrial cells at p10. Negative controls were incubated without primary antibody (e).
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another possibility is that the presence of myofibroblast
type cells is due to the nature of the cell culture technique.
Future work will seek to validate this and compare expres-
sion of myofibroblast markers within myometrial tissues.
Cardiac myofibroblasts stain positively for both a smooth
muscle actin and vimentin [21] and since the cultured
human myometrial cells express both proteins, this evi-
dence could suggest that they may be myometrial myofi-
broblasts. Myofibroblasts are involved in wound healing,
remodeling of the extracellular matrix, as well as the
development of fibrosis in pathological states [22,23]. For
example, exposure to allergens can increase the number of
myofibroblasts in the lung [24]. Myofibroblasts may origi-
nate by differentiation of fibroblast cells or de-differentia-
tion of smooth muscle cells [21-23]. Thus, with the
extensive growth and remodeling that occurs in the uterus
during pregnancy, along with the restoration to the non-
pregnant size and function following delivery, it may not
be surprising, that the pregnant uterus could contain
myofibroblasts.
An early report establishing human myometrial cells in
culture found that the cells were stable for up to one year
with no morphological changes [25]. However, there is
concern that the lifespan of primary cultured cells is finite
and that they eventually become senescent and unrespon-
sive. A phenomenon known as the Hayflick Limit pro-
poses that cell populations are capable of dividing for a
fixed number of times before reaching senescence [26]. To
address the limited lifespan of primary cells in culture
immortalized cells lines have been produced either by
transfecting telomerase expression vectors into primary
cells [27] or transforming cells with the human papilloma-
virus or the SV-40 large T antigen [28-30]. It has been
suggested that cell manipulation to achieve immortaliza-
tion may cause a fundamental change in the growth of the
cells that is no longer truly representative of the tissue of
origin [31], calling into question whether such immorta-
lized cell lines are truly representative of the tissue of ori-
gin, while other studies have reported that introduction of
telomerase does not necessarily produce ‘cancer-like’
behaviour or ‘malignant’ properties in immortalized cells
[32,33].
Ten years ago, non-pregnant human myometrial cells
were immortalized using telomerase and investigated for
their ability to retain characteristics of the myometrium.
The telomerase-immortalized cells did express smooth
muscle markers (a smooth muscle actin, calponin, caldes-
mon) but the study did not investigate the presence of
fibroblast markers within the cells. The authors report
that primary non-pregnant myometrial cells senesced after
about 8 weeks in culture whereas the immortalized cells
were still actively dividing after 10 months [9]. The con-
cern about immortalized cells versus primary cells still
persists, and many previous studies, including our own,
have used primary cells only at low passages, typically p5
and lower [34], thus obtaining a continued supply of myo-
metrial biopsies can be rate-limiting for the research.
However, our data demonstrate that these cells can be
maintained in culture for longer periods (to at least p10 as
demonstrated) without loss of viability or response to IL-
1b, for example. Condon et al., [9] also demonstrated that
the immortalized cells maintained their ability to respond
to oxytocin, which we have also shown in primary myo-
metrial cells as oxytocin continued to stimulate calcium
release by primary cells [35].
An additional area to explore would be to compare pas-
saged cells with freshly isolated cells (p0) and/or tissue
-explants which is a limitation of the current study. One
of the difficulties is the ability to obtain sufficient fresh
human myometrial tissue to perform the studies. How-
ever, based on the current data work is ongoing within
our laboratory to develop additional models of myometrial
tissue explants.
Comparison of our paired upper and lower segment
myometrial cells (each pair being isolated from biopsies of
the same uterus but distinct regions) revealed a number of
clear differences. For example, COX-2 mRNA expression
was significantly greater in lower segment myometrial
cells compared to upper segment cells (Figure 4), which is
consistent with previously reported data from myometrial
tissues [5-7]. Regional differences in gene expression have
also been reported for the oxytocin receptor [3,7], con-
nexin 43 [5,7], and the prostaglandin E2 receptors [4,2]. In
addition, we show connexin 43 and vimentin mRNA
expression is significantly higher in lower segment cells
compared to the upper segment myometrial cells (Figure
2B). In contrast, calponin mRNA expression was not sig-
nificantly different between upper or lower cells. Taken
together, these observations support the concept of a func-
tional regionalization of the upper and lower segment of
the human uterus. Of importance to note is that the sig-
nificant difference in COX-2 expression between upper
and lower segment cells (Figure 4A) that is also main-
tained from p1 through p10 (Figure 5). Both the upper
and the lower segment cells maintain the ability to
respond to IL-1b treatment in terms of increased COX-2
expression. However, expression of COX-2 is already sig-
nificantly higher in lower segment cells compared to the
upper segment cells, this is in keeping with the expression
pattern observed in myometrial tissues [5]. The ability to
specifically isolate and culture both upper and lower seg-
ment human myometrial cells will aid investigation of the
hypothesis of functional regionalization of the pregnant
uterus and provide valuable knowledge about the mechan-
ism underlying the process of human labour.
In summary, the results of this study advocate the
use of primary cultured human myometrial cells to
study the expression and regulation of pregnancy- and
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labour-associated genes within the human uterus. Human
myometrial cells appear to retain molecular memory of
their origin and maintain their ability to respond to the
inflammatory stimulus IL-1b for at least ten passages.
Moreover, these cells are not subject to additional manipu-
lations in order to immortalize a cell phenotype. Future
work will include further molecular and functional charac-
terization of the myometrial cell subtypes within the human
uterus.
Conclusions
Primary human myometrial cells isolated from two distinct
regions of the pregnant uterus offer a useful model for the
study of regional functional differences and mechanistic
pathways involved in the onset of human labour.
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